Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05

ClinicalTrials.gov ID: NCT01725269

Public ClinicalTrials.gov record NCT01725269. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:55 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Open-Label Study to Evaluate the Intermediate/Long Term Safety and Efficacy of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The AIR001-CS05 study evaluated the safety and efficacy (effectiveness) of AIR001 over 16 weeks in subjects who have PAH. The purpose of the AIR001-CS06 study is to evaluate the intermediate / long-term safety of AIR001 in subjects who have completed the AIR001-CS05 study. Assessments to evaluate the effectiveness of the study drug will include measurements of exercise ability and evaluations of PAH disease symptoms.

Study identification

NCT ID
NCT01725269
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aires Pharmaceuticals, Inc.
Industry
Enrollment
17 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 2013 (Type not available)
Primary completion
Apr 2014 (Actual)
Completion
Apr 2014 (Actual)
Last update posted
Apr 9, 2014

2013 – 2014

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
15
Facility City State ZIP Site status
UCSD Medical Center La Jolla California 92037 —
UCLA Medical Center Torrance California 90509 —
University of Colorado Denver Aurora Colorado 80045 —
Kentuckiana Pulmonary Associates Louisville Kentucky 40202 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Tufts Medical Center Boston Massachusetts 02111 —
Brigham and Women's Hospital Boston Massachusetts 02115 —
Boston University School of Medicine Boston Massachusetts 02118 —
Washington University School of Medicine St Louis Missouri 63110-1093 —
Duke University Medical Center Durham North Carolina 27710 —
University of Cincinnati Cincinnati Ohio 45267 —
The Ohio State University Medical Center Columbus Ohio 43210 —
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213 —
University of Texas Southwestern Medical Center Dallas Texas 75390 —
Adaani Frost, M.D. Houston Texas 77030 —
Inova Fairfax Hospital Falls Church Virginia 22042 —
Aurora St. Luke's Medical Center Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01725269, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 9, 2014 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01725269 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →